Intended for healthcare professionals

News

Pfizer’s open data policy should include trials of off-label uses, say critics

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7327 (Published 06 December 2013) Cite this as: BMJ 2013;347:f7327